Skip to content

Depression: all studies

Page 1019 of 1,036: studies 10,181 to 10,190 of 10,358, newest first. Back to the depression overview

Research

Responses of serotonergic and non-serotonergic neurons in the rat nucleus raphe magnus to systemic lysergic acid diethylamide.

Neuroscience Research February 1986 J B Wei, C Y Chiang

Serotonergic and non-serotonergic neurons in the nucleus raphe magnus were identified by conduction velocities and spontaneous discharge rates. Eight of 13 serotonergic neurons were depressed by lysergic acid diethylamide (LSD) administration (40-50 micrograms/kg, i.p. or i.v.), while the others were non-responsive. Among 38 non-serotonergic neurons, 5 were depressed, 4 were excited and 29 were...

Actions of phencyclidine on rat locus coeruleus neurones in vitro.

Neuroscience February 1986 M G Lacey, G Henderson

Intracellular recordings were made from neurones in the rat locus coeruleus in a brain slice maintained in vitro. Phencyclidine and related psychotomimetic drugs, applied in known concentrations in the fluid bathing the slice, depressed responses to N-methyl-D-aspartic acid noradrenaline (in the presence of the uptake inhibitor desmethylimipramine) and [D-Ala2,MePhe4,Gly-ol5]enkephalin and also...

Studies on the specificity of neurochemical and behavioral effects of LSD-25.

Pharmacology, Biochemistry, and Behavior February 1986 S B Sparber, L P Dwoskin, M S Kleven

Brain perfusion experiments of conscious rats engaged in operant behavior and administered fluoxetine or LSD, with or without prior injection of 5-HTP, indicate there is probably more than one functional pool of 5-HT in the CNS. Furthermore, the fact that prior loading with the precursor is necessary before unmasking an effect of LSD suggests the LSD-sensitive pool is newly synthesized and...

Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity.

Psychopharmacology 1986 E T Iwamoto

The effects of phencyclidine (PCP) on locomotor activity were compared to those of the stereoisomers of N-allylnormetazocine (NAN) after acute administration to rats. PCP produced swaying and falling movements, increased sniffing behavior, and enhanced horizontal locomotor activity. d-NAN also induced swaying, falling, sniffing behavior and locomotion, and decreased rearing behavior. l-NAN...

KETAMINE ABREACTION - TWO CASE REPORTS

Indian Journal of Psychiatry October 1, 1985 Golechha Gr, Rao Av, Ruggu Rk

Ketamine is a rapid acting parentrally administered non barbiturate anaesthetic agent with minimum cardio respiratory depressant effect as compared to others (Paul et al 1982). It is in clinical use for more than ten years and used safely in aged and critically ill patients (Lorhan & Limppman 1971, Barson and Aren 1974). In sub-anaesthetic doses it has been safely used to produce obstetrical...

The clinical use of mindfulness meditation for the self-regulation of chronic pain.

Journal of Behavioral Medicine June 1985 Jon Kabat‐zinn, Leslie Lipworth, Robert Burney

Ninety chronic pain patients were trained in mindfulness meditation in a 10-week Stress Reduction and Relaxation Program. Statistically significant reductions were observed in measures of present-moment pain, negative body image, inhibition of activity by pain, symptoms, mood disturbance, and psychological symptomatology, including anxiety and depression. Pain-related drug utilization decreased...

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

Psychopharmacology 1985 Françis C. Colpaert, Theo Meert, C J Niemegeers et al.

The newly synthesized compound and putative 5-HT2 antagonist ritanserin, but not the structurally related compound R 56413, resembles pirenperone in that it acts as a pure antagonist in an LSD-saline drug discrimination assay in the rat. Ritanserin exceeded pirenperone in terms of behavioral specificity; the lowest effective dose of ritanserin in antagonizing LSD was one order of magnitude...

Characterization of 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex.

Journal of Neurochemistry September 1984 M J Kadan, A M Krohn, M J Evans et al.

125I-Lysergic acid diethylamide (125I-LSD) is the first 125I-labeled ligand for serotonin receptor studies. Its binding to rat frontal cortex membranes is saturable, reversible, and stereospecific. Specific binding is linearly dependent on tissue concentration and represents 70-80% of the total binding. Scatchard plots of the binding data are linear with a KD of 1.5 nM, a Bmax of 12.4 fmol/mg...

Dream dimension differences during a life change.

Psychiatry Research May 1, 1984 I Trenholme, R D Cartwright, G Greenberg

Dreams reported from laboratory awakening of stably married women differed from those of women undergoing divorce: The former dreamed of the experiment; the latter had more threat themes. Those coping well during the divorce had more positive motives in the last dream than those who were depressed. Dreams of the nondepressed divorcées increased in anxiety from first to last dream report,...